THERAPEUTIC COMPOUNDS FOR TREATING DYSLIPIDEMIC CONDITIONS
The present invention relates to novel LXR ligands of Formula I and the pharmaceutically acceptable salts, esters and tautomers thereof, which are useful in the treatment of dyslipidemic conditions, particularly depressed levels of HDL cholesterol.
-
Page 75
(2010/11/30)
Amino acid analogs. III. New syntheses of monomethyl- and monophenylglutamic acids
-
Gershon,Parmegiani,Giannasio,Krull
p. 1855 - 1858
(2007/10/05)
More Articles about upstream products of 30741-72-1